Penetrium: A Breakthrough in Overcoming Cold Tumors and Metastatic Cancer
/in Preclinical Research/by MaxPioglitazone: Diabetes Drug Shows Promise for Treating Prostate Cancer
/in Drug repurposing, Preclinical Research/by MaxNewsletter 18/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! As you probably know, last week was the week of AACR 2025 (American Association for Cancer Research) and AUA 2025 (American Urological Association), so we have a very packed newsletter! Enjoy the read! Stay strong and fight on! As […]
Transdermal Estradiol: A Cost-Saving, Quality-of-Life Boost for Prostate Cancer Therapy
/in Review/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Phase 2 Trial of Cu-64 SAR-bisPSMA Doubles Prostate Lesion Detection March 2, 2026
- Newsletter 9/2026 March 1, 2026
- CT Muscle Measure Guides Treatment Benefit in New Prostate Cancer: STAMPEDE Findings February 25, 2026
- Igermetostat Plus Enzalutamide Delivers Promising rPFS in Post-Abiraterone mCRPC February 25, 2026
